Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs FMmeds

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FMmeds head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 52 · Grade B−

FMmeds

Visit FMmeds Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 80 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make FMmeds a bad call — it's best for readers who want a named pharmacy and can confirm the full membership payment schedule before committing. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
66
Supply Reliability
95
82
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
82
Track Record
88
79
CoreAge RxBrief Score 94 · 80FMmeds

Price, coverage & the tracker

CoreAge RxFMmeds
Brief Score94/100 (A)80/100 (B−)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm plan and billing period

Compounded semaglutide/B12 starts at $95; full commitment and upfront payment unconfirmed. Terms use a 28-day membership cycle.

Full price details

Compounded semaglutide with B12 offered; complete current commitment and billing quote unknown; starting figure $95; earlier listing: From $225/mo (all doses, compounded)

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm plan and billing period

Compounded tirzepatide/B12 starts at $145; full commitment and upfront payment unconfirmed. Terms use a 28-day membership cycle.

Full price details

Compounded tirzepatide with B12 offered; complete current commitment and billing quote unknown; starting figure $145; earlier listing: From $265/mo (all doses, compounded)

CoverageUS only; restrictions by state, confirmed at intakeAdvertises all 50 states plus DC; confirm clinician and prescription eligibility in your location
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

FMmeds: Advertised starts are $95 semaglutide/$145 tirzepatide; full plan term and payment schedule unconfirmed. Terms describe a 28-day membership cycle.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.